RPID
Rapid Micro Biosystems Inc
NASDAQ: RPID · HEALTHCARE · MEDICAL DEVICES
$2.30
-6.50% today
Updated 2026-04-29
Market cap
$112.59M
P/E ratio
—
P/S ratio
3.35x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$2 – $5
Volume
0.2M
Rapid Micro Biosystems Inc (RPID) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-140.30%
Operating margin
-108.20%
ROE
-86.80%
ROA
-34.20%
Debt/equity
0.54x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $16.08M | — | 0.37% | — | — |
| 2011 | $10.97M | — | — | — | — |
| 2019 | $16.51M | $-21.17M | -1.42% | -112.85% | -128.22% |
| 2020 | $16.08M | $-37.08M | -50.20% | -189.96% | -230.63% |
| 2021 | $23.23M | $-73.52M | -33.32% | -203.31% | -316.48% |
| 2022 | $17.13M | $-60.81M | -49.85% | -368.99% | -354.91% |
| 2023 | $22.52M | $-52.47M | -24.36% | -251.18% | -232.99% |
| 2024 | $28.05M | $-46.89M | -0.39% | -177.96% | -167.16% |
| 2025 | $33.59M | $-47.12M | 22.65% | -141.10% | -140.30% |